With generic Semaglutide now widely available across South Delhi, more people in Greater Kailash are asking the same question: "Do I actually need GLP-1 therapy, or am I a candidate for it at all?" At Recompose Health, GK-1, New Delhi, this is exactly what a proper discovery consultation is designed to answer — not through self-diagnosis or online BMI calculators alone, but through a structured clinical assessment. This guide explains India's eligibility criteria for GLP-1 therapy, who should consider it, and why starting with a metabolic risk assessment matters more than starting with a prescription.
Free Metabolic Risk Assessment before any commercial or treatment conversation
Full clinical assessment covering BMI, metabolic history, sleep, and comorbidities
Physician-led eligibility review by specialists authorised to prescribe GLP-1 medication
Tiered programme placement based on BMI and comorbidity profile
Suitable for adults 32–58 across Greater Kailash and South Delhi
Body Mass Index (BMI) is calculated from height and weight, and it remains the primary screening tool used across India to assess obesity-related risk. A BMI of 27 is a clinically significant threshold — it's the point at which many Indian guidelines consider pharmacotherapy appropriate, provided a metabolic comorbidity is also present. This is different from Western BMI cutoffs, which are typically higher, reflecting the fact that South Asian bodies tend to accumulate visceral fat and develop metabolic complications at lower BMI levels than other populations.
| Criteria | Threshold | Clinical Relevance |
|---|---|---|
| BMI Alone | 30 or above | May qualify without additional comorbidity |
| BMI + Comorbidity | 27 or above | Requires at least one obesity-related condition |
| Type 2 Diabetes | Any BMI 27+ | Common qualifying comorbidity |
| Obstructive Sleep Apnoea | Any BMI 27+ | Assessed alongside respiratory specialist review |
| Fatty Liver Disease | Any BMI 27+ | Confirmed via ultrasound or Fibroscan |
| Dyslipidaemia or Hypertension | Any BMI 27+ | Assessed via lipid panel and blood pressure history |
Tip: As of March 2026, Indian regulatory authorities restrict GLP-1 prescribing to endocrinologists, internal medicine specialists, and cardiologists. General practitioners are explicitly excluded — always confirm your prescribing physician's specialist credentials.
Not everyone with a qualifying BMI is automatically a good candidate for GLP-1 medication. A proper clinical evaluation exists precisely to catch cases where medication may be inappropriate or requires additional caution:
Patients with a personal or family history of certain thyroid conditions
Patients with a history of pancreatitis
Pregnant or breastfeeding individuals
Patients with significant gastrointestinal conditions affecting gastric emptying
Individuals whose primary goal is cosmetic weight loss without any metabolic comorbidity
This is why Amylase/Lipase, thyroid function, and renal function are part of standard baseline lab screening before GLP-1 initiation — to rule out contraindications before treatment begins, not after.
| Step | What Happens |
|---|---|
| 1. Free Risk Assessment Call | 15-minute call to review BMI, comorbidities, and goals |
| 2. Discovery Consult | Full clinical assessment with lead physician; tier placement decided |
| 3. Baseline Labs | CBC, LFT, KFT, lipid panel, HbA1c, thyroid, amylase/lipase, imaging |
| 4. Lab Review & Initiation | GLP-1 initiated only if clinically indicated and safe |
Warning: Do not self-prescribe or source GLP-1 medication without a physician evaluation. Cheaper generic availability does not mean self-administration is safe — dosage titration, contraindication screening, and lab monitoring require clinical oversight.
Once eligibility is confirmed, Recompose Health places patients into one of three tiers based on BMI, comorbidity burden, and treatment goals:
| Tier | Target Profile | Duration |
|---|---|---|
| Essential | BMI 27–32, lifestyle-driven, lower comorbidity burden | 3 months |
| Advanced | BMI 32–40, metabolic disease, 1–2 comorbidities | 6 months |
| Precision | Complex obesity, multiple comorbidities, pre-bariatric | 8 months |
Many patients in Greater Kailash and South Delhi approach GLP-1 therapy backwards — starting with medication and only later discovering whether it was clinically appropriate for their profile. Recompose Health reverses this sequence: a free Metabolic Risk Assessment comes first, followed by a full discovery consult with Dr. Bidyut, and only then — if clinically indicated — does GLP-1 initiation happen, alongside dietician, psychologist, and sleep specialist support.
Find Out If You Qualify — Book a Free Metabolic Risk Assessment
Serving Greater Kailash and South Delhi — physician-led eligibility review
Call: +91 78978 66359
Location: GK-1, New Delhi
Instagram: @recomposehealth
Q. What BMI is required for GLP-1 therapy in India?
Indian clinical guidelines generally recommend pharmacotherapy for adults with a BMI of 30 or above, or a BMI of 27 or above with at least one obesity-related comorbidity such as Type 2 diabetes, sleep apnoea, fatty liver disease, dyslipidaemia, or hypertension.
Q. Can any doctor prescribe GLP-1 medication in India?
No. As of March 2026, only endocrinologists, internal medicine specialists, and cardiologists are authorised to prescribe GLP-1 receptor agonists in India. General practitioners are explicitly excluded from prescribing.
Q. What tests are done before starting GLP-1 therapy?
Baseline labs typically include CBC, liver function tests, kidney function tests, lipid panel, HbA1c, thyroid function, and amylase/lipase, along with imaging such as ultrasound, Fibroscan, or DEXA depending on your clinical profile.
Q. Do I need GLP-1 medication to join Recompose Health?
No. The Essential tier is designed for lifestyle-driven weight management without GLP-1 medication. GLP-1 therapy is only included in the Advanced and Precision tiers, and only when clinically indicated.
Q. How do I book an eligibility assessment in Greater Kailash?
Call Recompose Health at +91 78978 66359 or book a free 15-minute Metabolic Risk Assessment call to review your BMI, comorbidities, and treatment options with our care team.
To Book an Appointment : +91 8448046304
Powered By Docfyn
